Oncorus Financials

ONCRDelisted Stock  USD 0.04  0.01  14.71%   
Based on the key indicators related to Oncorus' liquidity, profitability, solvency, and operating efficiency, Oncorus is not in a good financial situation at the moment. It has a very high risk of going through financial straits in November.
  
Understanding current and past Oncorus Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Oncorus' financial statements are interrelated, with each one affecting the others. For example, an increase in Oncorus' assets may result in an increase in income on the income statement.

Oncorus Stock Summary

Oncorus competes with Apollomics, Pyxis Oncology, Zura Bio, Altamira Therapeutics, and Elevation Oncology. Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Oncorus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS68236R1032
Business Address50 Hampshire Street,
SectorHealthcare
IndustryBiotechnology
BenchmarkDow Jones Industrial
Websitewww.oncorus.com
Phone857 320 6400
CurrencyUSD - US Dollar

Oncorus Key Financial Ratios

Oncorus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oncorus's current stock value. Our valuation model uses many indicators to compare Oncorus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oncorus competition to find correlations between indicators driving Oncorus's intrinsic value. More Info.
Oncorus is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Oncorus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Oncorus Market Pulse

 Quote0.0435
 Change(%)  14.71 
 Change0.01 
 Open0.051
 Low0.038
 High0.06
 Volume0
 ExchangeNASDAQ

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Oncorus is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Oncorus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Oncorus' financials are consistent with your investment objective using the following steps:
  • Review Oncorus' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Oncorus' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Oncorus' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Oncorus' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Oncorus October 24, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Oncorus help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oncorus. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oncorus based on widely used predictive technical indicators. In general, we focus on analyzing Oncorus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oncorus's daily price indicators and compare them against related drivers.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Oncorus Stock

If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios